Literature DB >> 1562458

DNA fragmentation, dATP pool elevation and potentiation of antifolate cytotoxicity in L1210 cells by hypoxanthine.

J B Kwok1, M H Tattersall.   

Abstract

Exogenous purines (greater than or equal to 10(-5)M) can modulate the cytotoxicity of methotrexate (MTX) in cultured cells, protecting cells at low MTX concentrations (less than or equal to 8 x 10(-8) M) and markedly potentiating its effect at higher concentrations. The ability of hypoxanthine (HX) to modulate the effects of two antifolates-ICI 198583 (an inhibitor of thymidylate synthetase) and piritrexim (PTX, a lipophilic inhibitor of DHFR)-was investigated using cultured mouse leukaemic cells, L1210. HX (10(-4) M) was found to potentiate only the cytotoxicity of DHFR inhibitors (MTS and PTX), increasing cell kill by 20-70 fold to the level achieved by an equivalent concentration (10(-5) M) of ICI 198583 alone. Agarose gel electrophoresis of DNA extracted from cells exposed to antifolates for 24 h demonstrated that the chromatin was cleaved into multimers of 200 base pairs. This pattern of DNA cleavage indicates cell death via apoptosis. The degree of DNA fragmentation was found to be closely linked to cytotoxicity. DNA fragmentation increased from 50% in cells treated with 10(-5) M MTX or PTX to 70% when HX was added with the drugs, a level achieved by 10(-5)M ICI 198583 alone. HX potentiation of cytotoxicity was correlated with a substantial increase in dATP in conjunction with low dTTP pools. The specific potentiation of DHFR inhibitors by HX may be due to their inhibition of purine synthesis with a concurrent rise in PRPP levels. Addition of HX with MTX substantially raised intracellular purine levels via the salvage pathway as indicated by ribonucleotide pool measurements. ICI 198583, on the other hand, stimulated de novo purine synthesis with or without added HX. Treatment with MTX plus HX or ICI 198583 (with or without HX) caused a reduction of dTTP pools to 8% of untreated control and excess dATP accumulation. The subsequent elevation (to 300% of control) of the dATP pool may provide a signal for endonucleolytic fragmentation of DNA and subsequent cell death.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562458      PMCID: PMC1977543          DOI: 10.1038/bjc.1992.104

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  "Thymineless" death in androgen-independent prostatic cancer cells.

Authors:  N Kyprianou; J T Isaacs
Journal:  Biochem Biophys Res Commun       Date:  1989-11-30       Impact factor: 3.575

2.  Antifolate drug interactions: enhancement of growth inhibition due to the antipurine 5,10-dideazatetrahydrofolic acid by the lipophilic dihydrofolate reductase inhibitors metoprine and trimetrexate.

Authors:  J Galivan; Z Nimec; M Rhee; D Boschelli; A L Oronsky; S S Kerwar
Journal:  Cancer Res       Date:  1988-05-01       Impact factor: 12.701

3.  Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.

Authors:  S H Kaufmann
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

4.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

5.  Chromatographic analysis of purine precursors in mouse L1210 leukemia.

Authors:  M E Sant; A Poiner; M C Harsanyi; S D Lyons; R I Christopherson
Journal:  Anal Biochem       Date:  1989-10       Impact factor: 3.365

6.  Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death.

Authors:  A Yoshioka; S Tanaka; O Hiraoka; Y Koyama; Y Hirota; D Ayusawa; T Seno; C Garrett; Y Wataya
Journal:  J Biol Chem       Date:  1987-06-15       Impact factor: 5.157

7.  Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism.

Authors:  E Cadman; R Heimer; L Davis
Journal:  Science       Date:  1979-09-14       Impact factor: 47.728

Review 8.  The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells.

Authors:  M Meuth
Journal:  Exp Cell Res       Date:  1989-04       Impact factor: 3.905

9.  Synchronisation of cancer cell lines of human origin using methotrexate.

Authors:  S Sen; E Erba; M D'Incalci
Journal:  Cytometry       Date:  1990

10.  Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.

Authors:  S Seto; C J Carrera; D B Wasson; D A Carson
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

View more
  5 in total

1.  Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis.

Authors:  Partha Palit; Abhijit Hazra; Arindam Maity; R S K Vijayan; Prabu Manoharan; Sukdeb Banerjee; Nirup B Mondal; Nanda Ghoshal; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

2.  Regulation of the salvage pathway of deoxynucleotides synthesis in apoptosis induced by growth factor deprivation.

Authors:  F J Oliver; M K Collins; A López-Rivas
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

3.  Detection of DNA strand breaks associated with apoptosis in human brain tumors.

Authors:  S Nakagawa; T Shiraishi; S Kihara; K Tabuchi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid.

Authors:  E Erba; S Sen; C Sessa; F L Vikhanskaya; M D'Incalci
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

5.  Preclinical cellular pharmacology of LY231514 (MTA): a comparison with methotrexate, LY309887 and raltitrexed for their effects on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells.

Authors:  V J Chen; J R Bewley; S L Andis; R M Schultz; P W Iversen; C Shih; L G Mendelsohn; D E Seitz; J L Tonkinson
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.